Kibabii University

Prof. Abonyo Speaks on Efficacy of Lung Surfactant on COVID-19 Induced Acute Respiratory Distress Syndrome (ARDS)

Since lack of oxygen is what kills alot of people with COVID-19, there is a possibility that lung surfactant- a soapy substance released by the lungs enabling them to relax and contract easily when breathing in and out- can help increase the patients’ accessibility to oxygen thus, reduce mortality as it increases their level of recovery.

Prof Barack Otieno Abonyo, Medical Physiologist and Registrar Planning Partnership, Research and Innovation at Kibabii University, said during a virtual media briefing with Africa Science Media Centre (AfriSMC) on Efficacy of Lung Surfactant on COVID-19 Induced Acute Respiratory Distress Syndrome (ARDS).

Access full story here https://scienceafrica.co.ke/lung-surfactant-possible-treatment-for-ards-in-covid-19-patientslung-surfactant-possible-treatment-for-acute-respiratory-distress-syndrome-in-covid-19-patients/

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp